Phenomix (San Diego, CA) a drug discovery and development company focused on novel drugs to inhibit therapeutic targets in the protease and kinase families.The most advanced programs are for treatment of Type 2 diabetes and for treatment of hepatitis C. The deal was led by Nomura Phase4 Ventures and was joined by JP Morgan Partners, Delphi Ventures, Baker Brothers Life Sciences Capital, Alta Partners, Sofinnova Ventures, Bay City Capital, CMEA Ventures, Novartis Venture Fund and GBS Venture Partners.